Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product

Molecules and Cells

Volumn 19, Issue 1, 2005, Pages 23-30

  Park, Yongjae ^a   Hong, Sunghoi ^a   Kim, Sung Jo ^a   Kang, Seongman ^a  

^a Korea University   (South Korea)

Author keywords

Ataxin 1; Polyglutamine; Proteasome; SAR; SCA1

Indexed keywords

ATAXIN 1; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; POLYGLUTAMINE; PROTEASOME; REGULATOR PROTEIN; ATAXIN-1; ENHANCED GREEN FLUORESCENT PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; REPORTER GENE; UBIQUITINATION; VECTOR CONTROL; WESTERN BLOTTING; CELL LINE; CHEMISTRY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN QUATERNARY STRUCTURE; SPINOCEREBELLAR DEGENERATION;

ATAXIA;

CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HUMANS; KIDNEY; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, QUATERNARY; SPINOCEREBELLAR ATAXIAS; TRANSFECTION;

EID: 22844451581     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
2. Andreatta, C., Nahreini, P., Hovland, A. R., Kumar, B., Edwards-Prasad, J., et al. (2001) Use of short-lived green fluorescent protein for the detection of proteasome inhibition. Biotechniques 30, 656-660.
3. Banerjee, D. and Liefshitz, A. (2001) Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination. Anticancer Res. 21, 3941-3947.
4. Bence, N. F., Sampat, R. M., and Kopito, R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
5. Brown, R. H. Jr. (1998) SOD1 aggregates in ALS: cause, correlate or consequence? Nat. Med. 4, 1362-1364.
6. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
7. Chen, H. K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., et al. (2003) Interaction of akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113, 457-468.
8. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320.
9. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Harper, J. D., et al. (2000) Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann. N. Y. Acad. Sci. 920, 42-45.
10. Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., et al. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19, 148-154.
11. Cummings, C. J., Orr, H. T., and Zoghbi, H. Y. (1999) Progress in pathogenesis studies of spinocerebellar ataxia type 1. Philos. Trans. R Soc. Lond. B Biol. Sci. 354, 1079-1081.
12. Cummings, C. J., Sun, Y., Opal, P., Antalffy, B., Mestril, R., et al. (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511-1518.
13. David, G., Abbas, N., Stevanin, G., Durr, A., Yvert, G., et al. (1997) Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 17, 65-70.
14. Davidson, J. D., Riley, B., Burright, E. N., Duvick, L. A., Zoghbi, H. Y., et al. (2000) Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein. Hum. Mol. Genet. 9, 2305-2312.
15. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
16. Emamian, E. S., Kaytor, M. D., Duvick, L. A., Zu, T., Tousey, S. K., et al. (2003) Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375-387.
17. Hong, S., Kim, S. J., Ka, S., Choi, I., and Kang, S. (2002) USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Mol. Cell. Neurosci. 20, 298-306.
18. Jana, N. R., Zemskov, E. A., Wang, G., and Nukina, N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cyto- chrome c release. Hum. Mol. Genet. 10, 1049-1059.
19. Johnston, J. A., Ward, C. L., and Kopito, R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898.
20. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8, 221-228.
21. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
22. Keller, J. N., Hanni, K. B., and Markesbery, W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
23. Kim, S.-J., Kim, T.-S., Kim, I. Y., Hong, S., Rhim, H., et al. (2003a) Polyglutamine-expanded ataxin-1 recruits Cu/Zn superoxide dismutase into the nucleus of HeLa cells. Biochem. Biophys. Res. Commun. 307, 660-665.
24. Kim, S.-J., Kim, T.-S., Hong, S., Rhim, H., Kim, I. Y., et al. (2003b) Oxidative stimuli affect polyglutmine aggregation cell death in human mutant ataxin-1-expressing cells. Nueurosci. Lett. 348, 21-24.
25. Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
26. Klement, I. A., Zoghbi, H. Y., and Orr, H. T. (1999) Pathogenesis of polyglutamine-induced disease: A model for SCA1. Mol. Genet. Metab. 66, 172-178.
27. Koide, R., Ikeuchi, T., Onodera, O., Tanaka, H., Igarashi, S., et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral- pallidoluysian atrophy (DRPLA). Nat. Genet. 6, 9-13.
28. Kouroku, Y., Fujita, E., Jimbo, A., Kikuchi, T., Yamagata, T., et al. (2002) Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum. Mol. Genet. 11, 1505-1515.
29. McNaught, K. S. and Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191-194.
30. McNaught, K. S., Olanow, C. W., Halliwell, B., Isacson, O., and Jenner, P. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589-594.
31. McNaught, K. S., Mytilineou, C., Jnobaptiste, R., Yabut, J., Shashidharan, P., et al. (2002) Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J. Neurochem. 81, 301-306.
32. Morishima-Kawashima, M. and Ihara, Y. (2002) Alzheimer's disease: beta-amyloid protein and tau. J. Neurosci. Res. 70, 392-401.
33. Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., et al. (1992) Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597-599.
34. Nahreini, P., Andreatta, C., and Prasad, K. N. (2001) Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells. Cell. Mol. Neurobiol. 21, 509-521.
35. Nishitoh, H., Matsuzawa, A., Tobiume, K., Saegusa, K., Takeda, K., et al. (2002) ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16, 1345-1355.
36. Orr, H. T. and Zoghbi, H. Y. (2001) SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Hum. Mol. Genet. 10, 2307-2311.
37. Pulst, S. M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X. N., et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 14, 269-276.
38. Rideout, H. J., Larsen, K. E., Sulzer, D., and Stefanis, L. (2001) Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein- immunoreactive inclusions in PC12 cells. J. Neurochem. 78, 899-908.
39. Sanchez, I., Mahlke, C., and Yuan, J. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379.
40. Shang, F., Nowell, T. R. Jr., and Taylor, A. (2001) Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp. Eye Res. 73, 229-238.
41. Skinner, P. J., Vierra-Green, C. A., Emamian, E., Zoghbi, H. Y., and Orr, H. T. (2002) Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. Neuromolecular Med. 1, 33-42.
42. Thompson, M. G., Thom, A., Partridge, K., Garden, K., Campbell, G. P., et al. (1999) Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: effect of the proteasome inhibitor MG-132. J. Cell. Physiol. 181, 455-461.
43. Yasuda, S., Inoue, K., Hirabayashi, M., Higashiyama, H., Yamamoto, Y., et al. (1999) Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells 4, 743-756.
44. Yokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H., et al. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem. Biophys. Res. Commun. 312, 1342-1348.
45. Zhang, M., Pickart, C. M., and Coffino, P. (2003) Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J. 22, 1488-1496.
46. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 15, 62-69.